PROCEPT BioRobotics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Net Income	-105.9	-87.15	-59.85	-53.02	-41.98
Depreciation & Amortization	3.82	4.32	2.98	2.7	1.49
Share-Based Compensation	19.13	10.34	3.8	2.17	1.99
Other Operating Activities	-25.06	-7.88	-4.26	-0.2	-5.33
Operating Cash Flow	-108	-80.38	-57.33	-48.34	-43.82
Capital Expenditures	-25.21	-2.65	-0.59	-0.23	-7.61
Change in Investments	0	0	0	0	50.76
Investing Cash Flow	-25.21	-2.65	-0.59	-0.23	43.15
Share Issuance / Repurchase	167.8	6.42	176.55	2.29	0.3
Debt Issued / Paid	0	-2.81	0	24.69	24.53
Other Financing Activities	-	-	85.57	79.8	1.69
Financing Cash Flow	167.8	3.61	262.12	106.77	26.53
Net Cash Flow	34.59	-79.42	204.19	58.2	25.86
Free Cash Flow	-133.21	-83.04	-57.93	-48.58	-51.43
Free Cash Flow Margin	-97.81%	-110.69%	-168.03%	-629.47%	-833.67%
Free Cash Flow Per Share	-2.82	-1.87	-3.52	-13.26	-23.29

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).